Los Angeles Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,810
| Closed | -$237K | – | 1573 |
|
|
2021
Q1 | $237K | Sell |
4,810
-10,545
| -69% | -$520K | ﹤0.01% | 1497 |
|
|
2020
Q4 | $646K | Sell |
15,355
-1,925
| -11% | -$81K | ﹤0.01% | 1104 |
|
|
2020
Q3 | $791K | Hold |
17,280
| – | – | ﹤0.01% | 911 |
|
|
2020
Q2 | $868K | Sell |
17,280
-125
| -0.7% | -$6.28K | ﹤0.01% | 902 |
|
|
2020
Q1 | $895K | Sell |
17,405
-18,125
| -51% | -$932K | 0.01% | 737 |
|
|
2019
Q4 | $2.2M | Sell |
35,530
-15,212
| -30% | -$940K | 0.01% | 624 |
|
|
2019
Q3 | $3.05M | Sell |
50,742
-18,360
| -27% | -$1.1M | 0.02% | 525 |
|
|
2019
Q2 | $5.83M | Buy |
69,102
+63,742
| +1,189% | +$5.38M | 0.03% | 412 |
|
|
2019
Q1 | $512K | Buy |
5,360
+1,070
| +25% | +$102K | ﹤0.01% | 1072 |
|
|
2018
Q4 | $304K | Buy |
4,290
+650
| +18% | +$46.1K | ﹤0.01% | 1095 |
|
|
2018
Q3 | $311K | Buy |
+3,640
| New | +$311K | ﹤0.01% | 1214 |
|